Catalyst Wire Dossier Catalyst Wire Dossier

Ipilimumab (Yervoy)

ipilimumab · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Ipilimumab (Yervoy), covering 2014-05-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer [Phase 2]

See pricing